A phase II study of irinotecan in patients with advanced hepatocellular carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/11148565

Cancer 2001 Jan 1 91 1 101-5

Download in:

View as

Triples

General Info

PMID
11148565